Active Biotech AB publ
STO:ACTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Active Biotech AB publ
Selling, General & Administrative
Active Biotech AB publ
Selling, General & Administrative Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Active Biotech AB publ
STO:ACTI
|
Selling, General & Administrative
-kr12.4m
|
CAGR 3-Years
6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
4%
|
|
|
Biogaia AB
STO:BIOG B
|
Selling, General & Administrative
-kr556.5m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Selling, General & Administrative
-kr741.3m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Selling, General & Administrative
-kr1.1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-18%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Selling, General & Administrative
-kr7.5B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-22%
|
|
|
BioArctic AB
STO:BIOA B
|
Selling, General & Administrative
-kr194.8m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
Active Biotech AB publ
Glance View
Active Biotech AB engages in the development of pharmaceutical products. The company is headquartered in Lund, Skane. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.
See Also
What is Active Biotech AB publ's Selling, General & Administrative?
Selling, General & Administrative
-12.4m
SEK
Based on the financial report for Dec 31, 2025, Active Biotech AB publ's Selling, General & Administrative amounts to -12.4m SEK.
What is Active Biotech AB publ's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
4%
Over the last year, the Selling, General & Administrative growth was 6%. The average annual Selling, General & Administrative growth rates for Active Biotech AB publ have been 6% over the past three years , 2% over the past five years , and 4% over the past ten years .
